233 related articles for article (PubMed ID: 12004461)
1. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
[TBL] [Abstract][Full Text] [Related]
2. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
[TBL] [Abstract][Full Text] [Related]
3. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
Yu HY
Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
[TBL] [Abstract][Full Text] [Related]
9. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
[TBL] [Abstract][Full Text] [Related]
10. Binding parameters of valproic acid to serum protein in healthy adults at steady state.
Kodama Y; Koike Y; Kimoto H; Yasunaga F; Takeyama M; Teraoka I; Fujii I
Ther Drug Monit; 1992 Feb; 14(1):55-60. PubMed ID: 1546390
[TBL] [Abstract][Full Text] [Related]
11. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
[TBL] [Abstract][Full Text] [Related]
12. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
[TBL] [Abstract][Full Text] [Related]
13. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
Heo G; Kim SH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
[TBL] [Abstract][Full Text] [Related]
14. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
[TBL] [Abstract][Full Text] [Related]
15. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
Dutta S; Faught E; Limdi NA
J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
[TBL] [Abstract][Full Text] [Related]
16. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
[TBL] [Abstract][Full Text] [Related]
19. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
[TBL] [Abstract][Full Text] [Related]
20. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
